Skip to main content
Erschienen in: International Journal of Clinical Oncology 5/2013

01.10.2013 | Review Article

Biological and molecular aspects of lymph node metastasis in gastro-intestinal cancer

verfasst von: Koshi Mimori, Yoshiharu Shinden, Hidetoshi Eguchi, Tomoya Sudo, Keishi Sugimachi

Erschienen in: International Journal of Clinical Oncology | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Recently, the existence of lymph node micrometastasis, including isolated tumor cells, has been the focus of the development of molecular diagnostic tools for lymph node metastasis in various malignant neoplasms, including those of the GI tract. In this review, we summarize recent molecular biological studies that might provide two reasons to explain the survival of single isolated cancer cells in lymph nodes. One is the specific characteristics of cancer cells, which can exist under severe circumstances, along with recent technological innovations to obtain expression profiles and sequencing from a single cell. The other is microenvironmental factors that support the formation of micrometastasis even in small numbers of cancer cells. The expression profile of whole transcriptome sequencing, genomic sequencing and epigenetic sequencing of a single cancer cell with tumorigenic properties in lymph node metastases should be disclosed in the near future.
Literatur
1.
Zurück zum Zitat Chang YT, Tseng HC, Huang CC et al (2011) Relative down-regulation of apoptosis and autophagy genes in colorectal cancer. Eur J Clin Invest 41:84–92PubMedCrossRef Chang YT, Tseng HC, Huang CC et al (2011) Relative down-regulation of apoptosis and autophagy genes in colorectal cancer. Eur J Clin Invest 41:84–92PubMedCrossRef
2.
Zurück zum Zitat Fukagawa T, Sasako M, Mann GB et al (2001) Immunohistochemically detected micrometastases of the lymph nodes in patients with gastric carcinoma. Cancer 92:753–760PubMedCrossRef Fukagawa T, Sasako M, Mann GB et al (2001) Immunohistochemically detected micrometastases of the lymph nodes in patients with gastric carcinoma. Cancer 92:753–760PubMedCrossRef
3.
Zurück zum Zitat Harrison LE, Choe JK, Goldstein M et al (2000) Prognostic significance of immunohistochemical micrometastases in node negative gastric cancer patients. J Surg Oncol 73:153–157PubMedCrossRef Harrison LE, Choe JK, Goldstein M et al (2000) Prognostic significance of immunohistochemical micrometastases in node negative gastric cancer patients. J Surg Oncol 73:153–157PubMedCrossRef
4.
Zurück zum Zitat Wikman H, Vessella R, Pantel K (2008) Cancer micrometastasis and tumour dormancy. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica. 116:754–770PubMedCrossRef Wikman H, Vessella R, Pantel K (2008) Cancer micrometastasis and tumour dormancy. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica. 116:754–770PubMedCrossRef
7.
Zurück zum Zitat Alix-Panabieres C, Vendrell JP, Pelle O et al (2007) Detection and characterization of putative metastatic precursor cells in cancer patients. Clin Chem 53:537–539PubMedCrossRef Alix-Panabieres C, Vendrell JP, Pelle O et al (2007) Detection and characterization of putative metastatic precursor cells in cancer patients. Clin Chem 53:537–539PubMedCrossRef
8.
Zurück zum Zitat Nash KT, Phadke PA, Navenot JM et al (2007) Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy. J Natl Cancer Inst 99:309–321PubMedCrossRef Nash KT, Phadke PA, Navenot JM et al (2007) Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy. J Natl Cancer Inst 99:309–321PubMedCrossRef
9.
Zurück zum Zitat Aguirre-Ghiso JA, Estrada Y, Liu D et al (2003) ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res 63:1684–1695PubMed Aguirre-Ghiso JA, Estrada Y, Liu D et al (2003) ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res 63:1684–1695PubMed
10.
11.
Zurück zum Zitat Porcile C, Bajetto A, Barbieri F et al (2005) Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation. Exp Cell Res 308:241–253PubMedCrossRef Porcile C, Bajetto A, Barbieri F et al (2005) Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation. Exp Cell Res 308:241–253PubMedCrossRef
12.
Zurück zum Zitat Cottingham K (2004) The single-cell scene. Anal Chem 76:235A–238APubMed Cottingham K (2004) The single-cell scene. Anal Chem 76:235A–238APubMed
13.
Zurück zum Zitat Brenner S, Johnson M, Bridgham J et al (2000) Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat Biotech 18:630–634CrossRef Brenner S, Johnson M, Bridgham J et al (2000) Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat Biotech 18:630–634CrossRef
14.
Zurück zum Zitat Kurimoto K, Saitou M (2010) Single-cell cDNA microarray profiling of complex biological processes of differentiation. Curr Opin Genet Dev 20:470–477PubMedCrossRef Kurimoto K, Saitou M (2010) Single-cell cDNA microarray profiling of complex biological processes of differentiation. Curr Opin Genet Dev 20:470–477PubMedCrossRef
15.
Zurück zum Zitat Islam S, Kjallquist U, Moliner A et al (2011) Characterization of the single-cell transcriptional landscape by highly multiplex RNA-seq. Genome Res 21:1160–1167PubMedCrossRef Islam S, Kjallquist U, Moliner A et al (2011) Characterization of the single-cell transcriptional landscape by highly multiplex RNA-seq. Genome Res 21:1160–1167PubMedCrossRef
16.
Zurück zum Zitat Hosch S, Kraus J, Scheunemann P et al (2000) Malignant potential and cytogenetic characteristics of occult disseminated tumor cells in esophageal cancer. Cancer Res 60:6836–6840PubMed Hosch S, Kraus J, Scheunemann P et al (2000) Malignant potential and cytogenetic characteristics of occult disseminated tumor cells in esophageal cancer. Cancer Res 60:6836–6840PubMed
17.
Zurück zum Zitat Kaifi JT, Reichelt U, Quaas A et al (2007) L1 is associated with micrometastatic spread and poor outcome in colorectal cancer. Mod Pathol 20:1183–1190PubMedCrossRef Kaifi JT, Reichelt U, Quaas A et al (2007) L1 is associated with micrometastatic spread and poor outcome in colorectal cancer. Mod Pathol 20:1183–1190PubMedCrossRef
18.
Zurück zum Zitat Karpanen T, Alitalo K (2008) Molecular biology and pathology of lymphangiogenesis. Annu Rev Pathol 3:367–397PubMedCrossRef Karpanen T, Alitalo K (2008) Molecular biology and pathology of lymphangiogenesis. Annu Rev Pathol 3:367–397PubMedCrossRef
19.
Zurück zum Zitat Lin EY, Pollard JW (2007) Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res 67:5064–5066PubMedCrossRef Lin EY, Pollard JW (2007) Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res 67:5064–5066PubMedCrossRef
20.
Zurück zum Zitat Caunt M, Mak J, Liang WC et al (2008) Blocking neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell 13:331–342PubMedCrossRef Caunt M, Mak J, Liang WC et al (2008) Blocking neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell 13:331–342PubMedCrossRef
21.
Zurück zum Zitat Schoppmann SF, Bayer G, Aumayr K et al (2004) Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 240:306–312PubMedCrossRef Schoppmann SF, Bayer G, Aumayr K et al (2004) Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 240:306–312PubMedCrossRef
22.
Zurück zum Zitat Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12:121–127PubMedCrossRef Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12:121–127PubMedCrossRef
23.
Zurück zum Zitat Campbell JJ, Butcher EC (2000) Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol 12:336–341PubMedCrossRef Campbell JJ, Butcher EC (2000) Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol 12:336–341PubMedCrossRef
24.
Zurück zum Zitat Mashino K, Sadanaga N, Yamaguchi H et al (2002) Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res 62:2937–2941PubMed Mashino K, Sadanaga N, Yamaguchi H et al (2002) Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res 62:2937–2941PubMed
25.
Zurück zum Zitat Gunn MD, Tangemann K, Tam C et al (1998) A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci (USA) 95:258–263CrossRef Gunn MD, Tangemann K, Tam C et al (1998) A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci (USA) 95:258–263CrossRef
26.
Zurück zum Zitat Yamashita M, Iwama N, Date F et al (2009) Macrophages participate in lymphangiogenesis in idiopathic diffuse alveolar damage through CCL19-CCR7 signal. Hum Pathol 40:1553–1563PubMedCrossRef Yamashita M, Iwama N, Date F et al (2009) Macrophages participate in lymphangiogenesis in idiopathic diffuse alveolar damage through CCL19-CCR7 signal. Hum Pathol 40:1553–1563PubMedCrossRef
27.
Zurück zum Zitat Kaifi JT, Yekebas EF, Schurr P et al (2005) Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. J Natl Cancer Inst 97:1840–1847PubMedCrossRef Kaifi JT, Yekebas EF, Schurr P et al (2005) Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. J Natl Cancer Inst 97:1840–1847PubMedCrossRef
Metadaten
Titel
Biological and molecular aspects of lymph node metastasis in gastro-intestinal cancer
verfasst von
Koshi Mimori
Yoshiharu Shinden
Hidetoshi Eguchi
Tomoya Sudo
Keishi Sugimachi
Publikationsdatum
01.10.2013
Verlag
Springer Japan
Erschienen in
International Journal of Clinical Oncology / Ausgabe 5/2013
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-013-0587-9

Weitere Artikel der Ausgabe 5/2013

International Journal of Clinical Oncology 5/2013 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.